View in EDS PDF Full Text

Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.
Authors: Schumacher HR Jr; University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, Pennsylvania, USA. schumacr@mail.med.upenn.edu, Sundy JS, Terkeltaub R, Knapp HR, Mellis SJ, Stahl N, Yancopoulos GD, Soo Y, King-Davis S, Weinstein SP, Radin AR
Corporate Authors: 0619 Study Group
Source: Arthritis and rheumatism [Arthritis Rheum] 2012 Mar; Vol. 64 (3), pp. 876-84.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium: Internet ISSN: 1529-0131 (Electronic) Linking ISSN: 00043591 NLM ISO Abbreviation: Arthritis Rheum Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22223180
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schumacher+HR+Jr%22">Schumacher HR Jr</searchLink>; University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, Pennsylvania, USA. schumacr@mail.med.upenn.edu<br /><searchLink fieldCode="AU" term="%22Sundy+JS%22">Sundy JS</searchLink><br /><searchLink fieldCode="AU" term="%22Terkeltaub+R%22">Terkeltaub R</searchLink><br /><searchLink fieldCode="AU" term="%22Knapp+HR%22">Knapp HR</searchLink><br /><searchLink fieldCode="AU" term="%22Mellis+SJ%22">Mellis SJ</searchLink><br /><searchLink fieldCode="AU" term="%22Stahl+N%22">Stahl N</searchLink><br /><searchLink fieldCode="AU" term="%22Yancopoulos+GD%22">Yancopoulos GD</searchLink><br /><searchLink fieldCode="AU" term="%22Soo+Y%22">Soo Y</searchLink><br /><searchLink fieldCode="AU" term="%22King-Davis+S%22">King-Davis S</searchLink><br /><searchLink fieldCode="AU" term="%22Weinstein+SP%22">Weinstein SP</searchLink><br /><searchLink fieldCode="AU" term="%22Radin+AR%22">Radin AR</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%220619+Study+Group%22">0619 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370605%22">Arthritis and rheumatism</searchLink> [Arthritis Rheum] 2012 Mar; Vol. 64 (3), pp. 876-84.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370605 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1529-0131 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200043591%22">00043591 </searchLink><i>NLM ISO Abbreviation: </i>Arthritis Rheum <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22223180
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/art.33412
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 876
    Titles:
      – TitleFull: Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schumacher HR Jr
      – PersonEntity:
          Name:
            NameFull: Sundy JS
      – PersonEntity:
          Name:
            NameFull: Terkeltaub R
      – PersonEntity:
          Name:
            NameFull: Knapp HR
      – PersonEntity:
          Name:
            NameFull: Mellis SJ
      – PersonEntity:
          Name:
            NameFull: Stahl N
      – PersonEntity:
          Name:
            NameFull: Yancopoulos GD
      – PersonEntity:
          Name:
            NameFull: Soo Y
      – PersonEntity:
          Name:
            NameFull: King-Davis S
      – PersonEntity:
          Name:
            NameFull: Weinstein SP
      – PersonEntity:
          Name:
            NameFull: Radin AR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2012 Mar
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 1529-0131
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Arthritis and rheumatism
              Type: main
ResultId 1